Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

PRPH
ProPhase Labs, Inc. Common Stock (DE)
stock NASDAQ

At Close
May 8, 2025 3:59:30 PM EDT
0.3040USD+6.294%(+0.0180)619,427
0.00Bid   0.00Ask   0.0000Spread
Pre-market
May 8, 2025 9:12:30 AM EDT
0.2979USD+4.161%(+0.0119)26,691
After-hours
May 8, 2025 4:28:30 PM EDT
0.3188USD+4.868%(+0.0148)100
OverviewOption ChainMax PainOptionsPrice & VolumeDividendsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 14, 2022
06:37AM EST  HC Wainwright & Co. Maintains Buy on ProPhase Labs, Raises Price Target to $15   Benzinga
Jan 13, 2022
11:47AM EST  ProPhase Labs Announces Record COVID-19 Testing In Q4 2021; Says Conducted Over 300K Tests; Says Expanded To Over 250 Labs, Up From 50 In Q3   Benzinga
08:15AM EST  Q1 2022 Testing Volumes will Significantly Exceed Previous Record Results from Q1 2021   GlobeNewswire Inc
Jan 5, 2022
08:30AM EST  ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present a corporate overview at the H.C. Wainwright Bioconnect 2022 Virtual Conference, which is taking place on January 10 13, 2022.   GlobeNewswire Inc
Dec 20, 2021
11:58AM EST  Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2021   Benzinga
06:26AM EST  HC Wainwright & Co. Initiates Coverage On ProPhase Labs with Buy Rating, Announces Price Target of $12   Benzinga
Dec 16, 2021
08:30AM EST  Precision Medicine division adds Industry Veteran Sam A. Beeler as Chief Strategy Officer; Diagnostics Division Promotes Alice Lioi and Jason Karkus to EVP and Co-Chief Operating Officers and Sergio Miralles toEVP/Chief Information Officer   GlobeNewswire Inc
Nov 23, 2021
04:15PM EST  ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, today announced that it has granted an inducement award to a new employee.   GlobeNewswire Inc
Nov 12, 2021
08:45AM EST  ProPhase Labs Q3 EPS $(0.26) May Not Compare To $0.07 Estimate, Sales $9.50M Beat $9.08M Estimate   Benzinga
08:30AM EST  ProPhase Labs Announces Financial Results for the Three Months   GlobeNewswire Inc
04:26AM EST  Earnings Scheduled For November 12, 2021   Benzinga
Nov 10, 2021
08:30AM EST  ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at the Q4 Investor Summit Conference, which is being held virtually from November 16 17, 2021.   GlobeNewswire Inc
Nov 5, 2021
08:30AM EDT  ProPhase Labs, Inc.(NASDAQ: PRPH), a diversified biotech and genomics company, will hold a conference call on Friday, November 12, 2021 at 11:00 a.m. Eastern time to discuss its results for the third quarter ended September 30, 2021. A press release detailing these results will be issued prior to the call.   GlobeNewswire Inc
Oct 13, 2021
01:38PM EDT  Dawson James Downgrades ProPhase Labs to Neutral   Benzinga
01:38PM EDT  UPDATE: ProPhase Sees Q4 COVID-19 Testing Sales Inline With Record Levels Set In Q1'21   Benzinga
01:38PM EDT  ProPhase Labs Sees Q3 COVID-19 Testing Sales Lower Than Q2 Testing Sales, Cites 'overall lower levels of COVID-19 testing during the summer months'   Benzinga
08:30AM EDT  ProPhase Labs Provides Business Update   GlobeNewswire Inc
Oct 11, 2021
11:57AM EDT  ProPhase Labs Interview That Was Scheduled At 12:30 p.m. ET On Benzinga's 'Power Hour' Has Been Cancelled   Benzinga
11:22AM EDT  EXCLUSIVE: ProPhase Labs Chairman & CEO, Ted Karkus To Appear On Benzinga's Power Hour Show At 12:30 p.m. EDT   Benzinga
08:59AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Monday, Oct. 11, 2021: SOFI, PTGX, GTLB, PRPH, AVDL   Benzinga
Oct 6, 2021
08:39AM EDT  ProPhase Labs To Present At LD Micro Main Event Conference Oct. 14   Benzinga
08:30AM EDT  ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will be presenting virtually at the 14th Annual LD Micro Main Event Conference.   GlobeNewswire Inc
Sep 22, 2021
08:30AM EDT  ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at the Benzinga Healthcare Small Cap Conference, which is being held virtually from September 29 30, 2021.   GlobeNewswire Inc
Sep 8, 2021
08:31AM EDT  ProPhase Labs Announces $6M Stock Repurchase Program   Benzinga
08:30AM EDT  ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, today announced that its Board of Directors has authorized the repurchase of up to $6 million in ProPhase common stock.   GlobeNewswire Inc
Sep 7, 2021
08:30AM EDT  ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at the H.C. Wainwright 23rd Annual Global Investment Conference, which is being held virtually from September 13 15, 2021.   GlobeNewswire Inc
Aug 16, 2021
08:30AM EDT  ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, today announced that Chairman and CEO Ted Karkus is scheduled to present at the following investor conferences:   GlobeNewswire Inc
Aug 13, 2021
08:28AM EDT  Recap: ProPhase Labs Q2 Earnings   Benzinga
08:12AM EDT  ProPhase Labs Q2 EPS $(0.09) Down From $0.01 YoY, Sales $9.10M Up From $3.62M YoY   Benzinga
08:11AM EDT  Company Provides Update on Significant Resurgence in Covid testing and Additional Insights into Previously Announced Nebula Genomics Acquisition   GlobeNewswire Inc
04:12AM EDT  Earnings Scheduled For August 13, 2021   Benzinga
Aug 11, 2021
08:34AM EDT  ProPhase Labs Acquires Nebula Genomics For ~$14.6M In Cash And Stock   Benzinga
08:30AM EDT  Nebula Founder and Renowned Harvard Scientist, George Church, Ph.D., to Spearhead ProPhase LabsNew Scientific Advisory Board   GlobeNewswire Inc
Aug 9, 2021
08:30AM EDT  ProPhase Labs, Inc.(NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Friday, August 13, 2021 at 11:00 a.m. Eastern time to discuss its results for the second quarter ended June 30, 2021. A press release detailing these results will be issued prior to the call.   GlobeNewswire Inc
Jul 12, 2021
08:30AM EDT  ProPhase Labs, Inc. (Nasdaq: PRPH) (ProPhase or the Company), a diversified medical science and technology company, today announced that Chief Executive Officer Ted Karkus will present a corporate overview at the Access to Giving Virtual Investor Conference being held on July 13 - 15, 2021.   GlobeNewswire Inc
Jul 1, 2021
08:30AM EDT  ProPhase Labs, Inc. (Nasdaq: PRPH) (ProPhase or the Company), a diversified medical science and technology company, announced today that it has retained CORE IR, a leading investor relations, public relations and strategic advisory firm, to assist the Company with investor relations, public relations and shareholder communications services.   GlobeNewswire Inc
Jun 28, 2021
08:30AM EDT  ProPhase Labs, Inc. (Nasdaq: PRPH) (ProPhase or the Company), a diversified medical science and technology company, today announces that it has been added to the Russell Microcap Index. This milestone became effective at the conclusion of the 2021 Russell Indexes annual reconstitution, which occurred immediately following the U.S. market opening today, June 28, 2021.   GlobeNewswire Inc
Jun 10, 2021
08:39AM EDT  ProPhase Labs Announces Formation Of ProPhase Precision Medicine And ProPhase Global Healthcare Subsidiaries   Benzinga
08:30AM EDT  ProPhase Precision Medicine, Inc. and ProPhase Global Healthcare, Inc. to Expand Opportunities in Genomics and International Testing Services   GlobeNewswire Inc
May 28, 2021
08:30AM EDT  ProPhase Labs to Present at LD Micro Invitational XI Virtual   GlobeNewswire Inc
May 13, 2021
04:36PM EDT  ProPhase Labs: Q1 Earnings Insights   Benzinga
04:35PM EDT  ProPhase Labs Q1 EPS $0.06 Misses $0.20 Estimate, Sales $15.27M Beat $11.98M Estimate   Benzinga
04:05PM EDT  First Quarter 2021 Revenue Increases 709% to $15.3 Million Driven by New Diagnostic Services Business   GlobeNewswire Inc
08:10AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use   Benzinga
May 6, 2021
08:33AM EDT  ProPhase Labs Reports Partnership With Dutchess County New York To Provide COVID-19 Testing, No Terms Disclosed   Benzinga
08:30AM EDT  State-Of-The-Art COVID-19 Testing Available for300,000 Residents toAid Reopening Efforts   GlobeNewswire Inc
Apr 22, 2021
08:34AM EDT  ProPhase Says Labs To Provide COVID-19 Testing For Oyster Bay Township In New York   Benzinga
08:30AM EDT  ProPhase Labs Will Offer State-Of-The-Art Testing to AidOyster Bay Communityin Reopening   GlobeNewswire Inc
Apr 15, 2021
08:01AM EDT  ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Thursday, May 13, 2021 at 4:30 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2021. A press release detailing these results will be issued prior to the call.   GlobeNewswire Inc
Mar 31, 2021
09:08AM EDT  ProPhase Labs FY 2020 EPS $(0.18) Vs $(0.27) YoY   Benzinga
09:05AM EDT  Recent Acquisition of Digital COVID-19 Vaccination and Testing Passport Transforms the Companys Portal Into a Universal Digital Certificate Solution and Uniquely Positions Company for Re-Opening Phase of Pandemic   GlobeNewswire Inc
06:14AM EDT  A Peek Into The Markets: US Stock Futures Mixed Ahead Of Walgreens Earnings, ADP Data   Benzinga
04:26AM EDT  Earnings Scheduled For March 31, 2021   Benzinga
Mar 30, 2021
05:10PM EDT  New Reporting App Simplifies Documentation of User Vaccination and Covid Testing Statue Easily Enables Clear Access to Air/Rail/Bus Travel, Concert & Sporting Events   GlobeNewswire Inc
Mar 25, 2021
02:45PM EDT  Highlights From Day 1 Of Benzinga's Biotech Small Cap Conference   Benzinga
Mar 24, 2021
11:39AM EDT  From BZ Biotech Conference: ProPhase Labs CEO Ted Karkus Says 'There's No Question Another Covid Wave Is Coming'; Co Could Benefit From Another Covid Wave With Testing   Benzinga
11:28AM EDT  From BZ Biotech Conference: ProPhase Labs CEO Ted Karkus Says In Terms Of Covid Testing, Co Is Well Situated For Another Covid Wave   Benzinga
11:25AM EDT  From BZ Biotech Conference: ProPhase Labs CEO Ted Karkus Says Co Sees Tremendous Activity Going Forward For Covid Testing   Benzinga
09:02AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Mar. 24, 2021: PRPH, QLGN, SRNE, GLSI, AMPE   Benzinga
Mar 23, 2021
07:12PM EDT  Benzinga's Biotech Small Cap Conference Schedule For Wednesday, Mar. 24, 2021   Benzinga
Mar 15, 2021
08:30AM EDT  ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Wednesday, March 31, 2021 at 4:30 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2020. A press release detailing these results will be issued prior to the call.   GlobeNewswire Inc
Feb 9, 2021
08:31AM EST  ProPhase Labs Begins Advanced, Saliva-based Viral PCR Multiplex-Testing For COVID-19, Influenza A & B, And Other Viruses After FDA Confirmation Of Two Emergency Use Authorizations   Benzinga
08:30AM EST  Company Integrates Spectrum Solutions SDNA-1000 Saliva Collection System for Advanced, Simultaneous Multi-Viral Detection of Infections and Viral Mutations   GlobeNewswire Inc
Feb 1, 2021
08:40AM EST  ProPhase Labs Says Old Bridge, New Jersey Lab Is Processing COVID-19 Tests At A Rate In Excess Of 2,500 Tests Per Day   Benzinga
08:30AM EST  Company to Host Business Update Shareholders Conference Call on February 10, 2021 at 11:00 a.m. Eastern Time   GlobeNewswire Inc
Jan 29, 2021
09:21AM EST  - Total Company Processing Capacity On Track to Reach 60,000 Tests Per Day   GlobeNewswire Inc
08:48AM EST  ProPhase Labs Announces Opening Of Large CLIA Lab COVID Testing Facility In Garden City, New York   Benzinga
Jan 21, 2021
04:30PM EST  ProPhase Labs, Inc. Announces Closing of Public Offering   GlobeNewswire Inc
Jan 19, 2021
02:58PM EST  Mid-Afternoon Market Update: Nasdaq Surges 1.5%; Aclaris Therapeutics Shares Spike Higher   Benzinga
12:16PM EST  Mid-Day Market Update: Crude Oil Rises Over 1%; ProPhase Labs Shares Plummet   Benzinga
10:19AM EST  Mid-Morning Market Update: Markets Open Higher; Goldman Sachs Earnings Top Views   Benzinga
Jan 18, 2021
10:20PM EST  ProPhase Labs Inc. (PRPH), a diversified medical science and technology company, said that it has priced an underwritten public offering of 3.00 million shares of common stock at $12.50 per share, for gross proceeds of $37.50 million.   RTTNews
09:50PM EST  ProPhase Labs Announces Pricing of Public Offering of Common Stock   GlobeNewswire Inc
Jan 15, 2021
05:21PM EST  ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has commenced a proposed underwritten public offering of its common stock.   GlobeNewswire Inc
Jan 11, 2021
08:30AM EST  ProPhase Labs to Present at the NobleCon17 Annual Small & Microcap   GlobeNewswire Inc
Jan 5, 2021
12:10PM EST  ProPhase Labs Announces $5.5M Offering Of Stock, Warrants   Benzinga
12:10PM EST  ProPhase Labs Announces $5.5 Million Registered Direct Offering of   GlobeNewswire Inc
Dec 8, 2020
04:17PM EST  ProPhase Labs Announces Execution Of A Lease For New Facility To 'provide a wide range of laboratory testing services for diagnosis, screening and evaluation of diseases, including COVID-19 and Respiratory Pathogen Panel ("RPP") Molecular tests.'   Benzinga
04:15PM EST  Company Expands to Meet Anticipated Demand for Increased Molecular Testing From New Business Opportunities Aiming For Capacity to Process 50,000 Tests per Day   GlobeNewswire Inc
Nov 16, 2020
08:42AM EST  ProPhase Labs Q3 EPS $(0.05) Down From $(0.04) YoY, Sales $3.80M Up From $2.77M YoY   Benzinga
08:30AM EST  ProPhase Labs Reports Financial Results for the Three and Nine   GlobeNewswire Inc
Nov 10, 2020
08:30AM EST  ProPhase Labs, Inc. (NASDAQ: PRPH) (ProPhase Labs), a diversified medical science and technology company, today announced that management will present at the Virtual Fall Investor Summit taking place November 16th 18th, 2020.   GlobeNewswire Inc
Nov 2, 2020
08:30AM EST  ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has completed the acquisition of Confucius Plaza Medical Laboratory Corp. (Confucius Labs), a Clinical Laboratory Improvement Amendments (CLIA) accredited laboratory headquartered in Old Bridge, New Jersey.   GlobeNewswire Inc
Oct 23, 2020
08:34AM EDT  ProPhase Labs Announces Definitive Agreement To Acquire CLIA Accredited Lab Certified For COVID-19 And Upper Respiratory Testing In All-Cash Transaction Valued At $2.5M   Benzinga
08:30AM EDT  ProPhase Labs Announces Definitive Agreement to Acquire CLIA   GlobeNewswire Inc
Oct 22, 2020
10:29AM EDT  Stocks Trading Near 52-Week Highs Just After Open On Thursday, Oct. 22, 2020: MXL, LOACR, PRPH, QELLU, PBI, LOACW, ACAMW, LPL, HBM, ACAM, CSX, ALACW, ERIC, SNA, AMTX, BCOV, EVK, ALGN, TC, PAG, CRSR, WHR, SQBG, STNE, IMMU, REPL, BOTZ, ATSG, SFIX, SID   Benzinga
Sep 30, 2020
05:05PM EDT  Company Enters into Consulting Agreement and Amended and Restated Promissory Note and Security Agreement with Predictive Laboratories, Inc. to Further These Plans   GlobeNewswire Inc
08:30AM EDT  ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, has engaged international investor relations specialists MZ Group (MZ) to lead a comprehensive strategic investor relations and financial communications program across all key markets.   GlobeNewswire Inc
Sep 23, 2020
04:10PM EDT  ProPhase Labs Reports At-The-Market Equity Facility, No Terms Disclosed   Benzinga
04:10PM EDT  ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today announced that it has entered into an at-the-market (ATM) equity offering sales agreement (the Sales Agreement) with A.G.P./Alliance Global Partners (A.G.P.), under which the Company may, from time to time, offer and sell shares of its common stock through AGP, as sales agent.   GlobeNewswire Inc
Sep 18, 2020
08:00AM EDT  ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today announced that it has closed on a $10 million unsecured debt financing. The Company has issued two unsecured, partially convertible, promissory notes for an aggregate principal amount of $10 million (the Notes).   GlobeNewswire Inc
08:00AM EDT  ProPhase Labs Reports $10M Unsecured Debt Financing   Benzinga
Aug 17, 2020
09:05AM EDT  What To When You Start The Day In The Red   Benzinga
Aug 11, 2020
10:31AM EDT  Shares of ProPhase Labs, Inc. (PRPH) surged 45% on Tuesday morning after the dietary supplement maker reported a second-quarter profit and revenues that improved from previous year.   RTTNews
08:50AM EDT  ProPhase Labs Q2 EPS $0.01 Up From $(0.11) YoY, Sales $3.62M Up From $1.65M YoY   Benzinga
08:48AM EDT  ProPhase Labs Reports Financial Results for the Three and Six   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC